NAC and Sulodexide increased the tPA/PAI-1 ratio in the cells treated with the post-COVID-19 serum to 1.6 ± 0.1 (p < 0.01) and 1.5 ± 0.1 (p < 0.05), respectively. This evidence concerns the gene PLAT and COVID-19.